Dec. 13, 2024 — Influenza or flu virus remains infectious in refrigerated raw milk for up to five days, according to a new study. The findings come at a time when outbreaks of bird flu -- a ...
Although a candidate bird flu vaccine has not yet been made commercially available, medical experts advise that people should get it once it is. Dr. Linda Yancey, an expert in infectious ...
As the Centers for Disease Control and Prevention (CDC) explains, bird flu is a disease caused by the influenza A virus. At the same time, recent CDC data shows that seasonal influenza A is rising ...
There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...
But not all influenza is the same. There are some notable differences between flu A and flu B strains. On the heels of a post-holiday COVID surge, flu cases and hospitalizations are ticking upwards.
Influenza A(H1N1)pdm09 and A(H3N2) are the predominant viruses as of the end of January, according to the CDC. Cases of flu A have continued to grow since the start of the season. There's no ...
Flu cases are high in California with respiratory virus season in full swing. About 20% of tests for influenza came back as positive in California for the week of Dec. 29 to Jan. 4, according to ...
Each flu season, there are two subtypes that are typically at play: influenza type A and influenza type B. Data from the Centers for Disease Control and Prevention shows seasonal flu activity ...
The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.
Influenza vaccination demonstrates consistent effectiveness of approximately 50% across all severity levels in children, with higher protection observed in younger children (age, 6 months to 8 ...
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...